13:34:19 EST Tue 29 Nov 2022
Enter Symbol
or Name

Login ID:
Tilray Brands Inc
Symbol TLRY
Shares Issued 490,818,135
Close 2022-09-22 C$ 3.78
Recent Sedar Documents

Tilray receives OK for THC25 distribution in Italy

2022-09-22 09:28 ET - News Release

Ms. Denise Faltischek reports


FL Group SRL, a division of Tilray Brands Inc.'s Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray's medical cannabis oral solution THC25 across the country.

Denise Faltischek, Tilray's chief strategy officer and head of international business, said: "Expanding our approved authorization into Italy once again proves our commitment to be the most responsible, trusted and market-leading cannabis company in the world with a portfolio of innovative and high-quality products that address the needs of the patients and consumers we serve. We remain dedicated and focused on working with regulators across international markets to advocate for responsible cannabis regulations, best practices and a reliable source of quality products."

In Italy, where medical cannabis authorization is limited, Tilray Medical has an established national pharmaceutical distribution network with FL Group to distribute Tilray's THC25 medical cannabis oral solution. Patients may obtain prescriptions for Tilray and other medical cannabis products in Italy through their medical doctors.

Tilray Medical is a leading provider of EU-GMP-certified (European Union good manufacturing practices) medical cannabis products in 22 countries with a comprehensive portfolio of THC (tetrahydrocannabinol) and CBD (cannabidiol) products. Each medical cannabis product that Tilray offers has been selected to ensure patients can receive both the highest product quality as well as consistency when it comes to supply of their medicinal cannabis products.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first EU-GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers and governments in 22 countries and across five continents.

About FL Group SRL

FL Group markets and distributes pharmaceutical, health care, orthopedic and electro-medical products in Italy. In 2015, FL Group became one of the first companies authorized by the Italian Ministry of Health to import and distribute medical cannabis. Today, FL Group specializes as a leader in pharmaceutical distribution of medical cannabis for therapeutic use, pharmaceutical medicines for human and veterinary use, and a traced supply chain of products for pharmacies of innovative products to meet the needs of its customer base across Italy.

About Tilray Brands Inc.

Tilray Brands is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is changing people's lives for the better -- one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body and soul while invoking well-being. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.